Recent Updates
Recently added Catalysts
ATHE Negative Sentiment Score: 30/100

Notification of cessation of +securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Wednesday

Key Takeaway: Alterity Therapeutics Limited has announced the cessation of 500,000 options (ATHAAG), which expired on September 11, 2023. The reason for this cessation is the lapse of conditional rights to these securities due to the failure to meet specified conditions. This event may affect the company's financial obligations and future equity structure. Following this cessation, the company's issued capital remains predominantly unchanged, with various other option classes still in place.

Market Sentiment Analysis

CONCERNS & RISKS

  • 500,000 options have ceased due to unmet conditions.
  • The cessation of these securities could indicate potential challenges in fulfilling obligations.

Full Press Release Details

ALTERITY THERAPEUTICS LIMITED
Date of this announcement
Wednesday September 13, 2023
Details of +securities that have ceased
ASX+security code Security description Number of +securities that have ceased The +securities have ceased due to Date of cessation
ATHAAG OPTION EXPIRING 29-NOV-2026 EX $0.0238 500,000 Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied 11/09/2023
Refer to next page for full details of the announcement
Part 1 - Announcement Details
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) provide the following information
about our issued capital.
1.2 Registered Number Type Registration Number
ABN 37080699065
Date of this announcement
Part 2 - Details of +equity securities or +debt securities that have
ASX +Security Code and Description
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238
Unquoted +equity securities that have ceased
Number of securities that have ceased
Reason for cessation
Lapse of conditional right to securities because the
conditions have not been, or have become incapable of being, satisfied
Date of cessation Is the entity paying any consideration for the cessation?
11/9/2023 No
Any other information the entity wishes to notify to
ASX about the cessation?
Part 3 - Issued capital following changes
Following the cessation of
the + securities the subject of this notification, the issued capital of the entity will comprise:
Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 2,439,897,618
Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 19,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 12,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAC : OPTION EXPIRING 23-NOV-2023 EX $0.07 674,694,939
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720
Note: the figures stated in the tables above are used
to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes
of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the
entity has advised ASX of a change to that class of +security in Part 2 of this form.

Frequently Asked Questions

What recent announcement did Alterity Therapeutics make?

Alterity Therapeutics announced the cessation of 500,000 options due to unmet conditions.

When did the cessation of options occur?

The cessation of options took place on September 11, 2023.

What is the reason for the cessation of options?

The options lapsed due to the conditional rights not being satisfied.

How many ordinary shares does Alterity have now?

Alterity currently has 2,439,897,618 ordinary fully paid shares.

Is Alterity paying for the cessation of these securities?

No, Alterity is not paying any consideration for the cessation.

Last updated: Sep 13, 2023